Three men face felony charges following a viral New Year's shooting from a Dallas overpass, with investigators linking suspects to a separate road-rage attack and uncovering a cache of firearms.
A mail carrier in Lauderhill faces three counts of animal cruelty following the release of surveillance footage allegedly showing him spraying a resident's three small dogs with a chemical irritant during his delivery route.
A rescue operation in Putnam County, Illinois, ended with one fatality and a second worker airlifted to hospital after both became buried in soybeans while working inside a grain storage bin.
Charles Broomfield, who once wore a '#1 Dad' lanyard, now faces murder charges after allegedly confessing to shooting his fiancée and her two teenage sons in their Grand Rapids home, while his own young child was spared.
Harris County deputies executing a parole warrant at a Channelview motel discovered the body of a 33-year-old man with multiple gunshot wounds. Authorities say the detained warrant subject is not currently linked to the killing.
Brendan Banfield's murder trial reaches its climax Friday with closing arguments after he testified he shot a man he found stabbing his wife. Prosecutors allege an elaborate murder-for-hire plot, while the defense claims a tragic act of self-defense.
President Donald Trump is expected to nominate Kevin Warsh, a former Federal Reserve governor with a notably more open stance toward Bitcoin, to lead the central bank. The anticipated move has already triggered market reactions and reshaped expectations for U.S. monetary policy.
At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.
While Morgan Stanley maintains an Overweight rating on PDD Holdings, the firm has removed the e-commerce giant from its Top Picks list, citing heightened regulatory scrutiny and a slower-than-expected consumer recovery in China.
Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.
A new lawsuit alleging wrongful termination and safety cover-ups, coupled with ongoing supply shortages, challenges the coffee giant's operational resilience and brand trust as its new CEO executes a critical recovery plan.
Vizsla Silver Corp. (VZLA) shares tumbled sharply Thursday after reports that 10 of its employees were abducted from company housing in Mexico, forcing a temporary halt to operations and rattling investor confidence amid broader weakness in silver prices.
Amid renewed threats of steep US tariffs, South Korean officials are scrambling to salvage a key trade deal, with high-level talks in Washington failing to yield an immediate breakthrough.
A deep dive into Pantech Group Holdings Berhad's valuation using a Discounted Cash Flow model suggests the stock may be trading close to its intrinsic value, offering investors a potential entry point in the industrial supplies sector.
With his term winding down, Federal Reserve Chair Jerome Powell offered rare, pointed advice to his eventual successor during a recent press conference, emphasizing the imperative of maintaining the central bank's independence from political influence.
A major consumer group has filed a complaint with the Competition and Markets Authority, alleging the pharmacy chains used inflated reference prices to make member discounts appear more substantial than they truly were.
